Tg launches 1 Bio, single-use biopharma scale-up hub

The IT Minister announced over `200 crore in new infrastructure upgrades by TGIIC

Hyderabad: In a major boost to India’s biologics and next-generation therapeutics ecosystem, Telangana, on Monday inaugurated 1 Bio, the nation’s first single-use bioprocess design and scale-up facility, marking a pivotal expansion of the Genome Valley innovation cluster. The facility was unveiled by Telangana’s Minister for IT, Electronics & Communications, and Industries & Commerce D Sridhar Babu, who described the launch as the “next wave of growth and leadership” for India’s biopharma sector.

Speaking at the event, Minister Sridhar Babu said, “As Genome Valley marks 25 years, we are setting the course for its next 25 years. 1 Bio is one of India’s most important steps toward democratising access to biologics scale-up and accelerating the journey from discovery to clinical readiness. With this facility, innovations can now advance to pilot and clinical stages in Hyderabad faster, more predictably, and at lower cost.”

To prepare Genome Valley for its next phase of expansion, the Minister announced over Rs200 crore in new infrastructure upgrades by TGIIC, including road widening, new greenfield roads, power augmentation, and landscaping and streetscaping improvements to enhance connectivity and ensure robust utility services within the cluster.

Special Chief Secretary (Industries & ITE&C) Sanjay Kumar highlighted Telangana’s dominant role in national and global life sciences output, noting that the State contributes 40 per cent of India’s pharma production and one-third of global vaccine supply. He said 1 Bio strengthens this leadership by giving innovators access to world-class bioprocess development capacity.

Related Posts

Ministry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra vires

The ministry of health and family welfare has declared the Pharmacy Council of India’s (PCI) recently notified regulation on the pharmacist recruitment, promotion and services as ultra vires and does…

Second Documented Case of Pan-Drug Resistant Candida auris Uncovered in Kenya

NAIROBI/GENEVA— In an alarming development that underscores the accelerating global crisis of antimicrobial resistance, researchers have confirmed the detection of a rare, pan-drug resistant strain of the high-priority fungal pathogen…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Ministry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra vires

Ministry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra vires

Second Documented Case of Pan-Drug Resistant Candida auris Uncovered in Kenya

Second Documented Case of Pan-Drug Resistant Candida auris Uncovered in Kenya

AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

NDLEA Intercepts Massive ₦6.98 Billion Tramadol Shipment Imported from India at Lagos Port

NDLEA Intercepts Massive ₦6.98 Billion Tramadol Shipment Imported from India at Lagos Port

Two More Pregnant Women In Rajasthan’s Kota Die From Kidney Complications

Two More Pregnant Women In Rajasthan’s Kota Die From Kidney Complications